Adaptive Biotechnologies Corporation
ADPT$2.81B
Mid CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaSEATTLE619 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 4, 2026
22dMarket Overview
Stock performance and key metrics
ADPT News
Catalyst Timeline
1 upcoming, 0 past
How ADPT's past catalysts played out
Drug Pipeline
No drugs found in this phase.
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is Adaptive Biotechnologies Corporation's next FDA catalyst?→
Adaptive Biotechnologies Corporation's (ADPT) next tracked catalyst is a Earnings expected August 4, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ADPT biotech catalysts?→
Add ADPT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Adaptive Biotechnologies Corporation's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply